Press Releases

Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry’s Largest NGS-Based Proteomics Panel

May 19, 2025

Signios Bio Launches with AI-Driven Bioinformatics and Advanced Multiomics Platform to Power the Future of Precision Medicine and Drug Discovery

April 10, 2025

MedGenome Appoints Industry Veterans Felix Olale, M.D., Ph.D., as CEO and Jennifer Rose as Chief Commercial Officer to Lead U.S. Expansion

October 23, 2024

MedGenome boosts omic insights capabilities as the first commercial provider in the San Francisco Bay Area of California to bring PacBio Revio in-house with full service capability

July 18, 2024

MedGenome announces de novo Genome Assembly and Annotation Grant winners for 2024

May 2, 2024

MedGenome appoints Martin Dewhurst as Chairman of Advisory Board

November 28, 2023

MedGenome, in collaboration with PacBio, announces a de novo genome assembly and annotation grant to empower non-model organism research

November 21, 2023

MedGenome achieves 10x Genomics Certified Service provider qualification for single cell sequencing

November 7, 2023

MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting

April 10, 2023

Gallbladder cancer vaccine candidates identified

August 24, 2020
Load More